Filing Details
- Accession Number:
- 0001192482-19-000428
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-13 20:57:28
- Reporting Period:
- 2019-11-08
- Accepted Time:
- 2019-11-13 20:57:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1561921 | Tela Bio Inc. | TELA | Surgical & Medical Instruments & Apparatus (3841) | 455320061 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1790214 | Matt Zuga | C/O Highcape Partners Qp, L.p. 10751 Falls Road, Suite 300 Baltimore MD 21093 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-11-08 | 10,220 | $13.00 | 12,675 | No | 4 | P | Indirect | By HighCape Partners, L.P. |
Common Stock | Acquisiton | 2019-11-08 | 75,901 | $13.00 | 260,808 | No | 4 | P | Indirect | By HighCape Partners QP, L.P. |
Common Stock | Acquisiton | 2019-11-13 | 269 | $0.00 | 12,944 | No | 4 | C | Indirect | By HighCape Partners, L.P. |
Common Stock | Acquisiton | 2019-11-13 | 2,931 | $0.00 | 15,875 | No | 4 | C | Indirect | By HighCape Partners, L.P. |
Common Stock | Acquisiton | 2019-11-13 | 19,982 | $0.00 | 280,790 | No | 4 | C | Indirect | By HighCape Partners QP, L.P. |
Common Stock | Acquisiton | 2019-11-13 | 217,816 | $0.00 | 498,606 | No | 4 | C | Indirect | By HighCape Partners QP, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By HighCape Partners, L.P. |
No | 4 | P | Indirect | By HighCape Partners QP, L.P. |
No | 4 | C | Indirect | By HighCape Partners, L.P. |
No | 4 | C | Indirect | By HighCape Partners, L.P. |
No | 4 | C | Indirect | By HighCape Partners QP, L.P. |
No | 4 | C | Indirect | By HighCape Partners QP, L.P. |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Preferred Stock | Disposition | 2019-11-13 | 493,357 | $0.00 | 19,982 | $0.00 |
Common Stock | Series A Preferred Stock | Disposition | 2019-11-13 | 6,643 | $0.00 | 269 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2019-11-13 | 5,377,928 | $0.00 | 217,816 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2019-11-13 | 72,417 | $0.00 | 2,931 | $0.00 |
Series B Preferred Stock | Warrant (right to buy) | Disposition | 2019-11-13 | 123,653 | $0.00 | 123,653 | $1.16 |
Common Stock | Warrant (right to buy) | Acquisiton | 2019-11-13 | 123,653 | $0.00 | 5,008 | $28.65 |
Series B Preferred Stock | Warrant (right to buy) | Disposition | 2019-11-13 | 1,665 | $0.00 | 1,665 | $1.16 |
Common Stock | Warrant (right to buy) | Acquisiton | 2019-11-13 | 1,665 | $0.00 | 67 | $28.65 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | 2017-01-18 | 2027-01-18 | No | 4 | C | Indirect |
123,653 | 2017-11-13 | 2027-01-18 | No | 4 | C | Indirect |
0 | 2017-01-18 | 2027-01-18 | No | 4 | C | Indirect |
1,665 | 2019-11-13 | 2027-01-18 | No | 4 | C | Indirect |
Footnotes
- Reflects 2,455 shares of common stock received by the reporting person as a payment-in-kind dividend on Series A Preferred Stock and Series B Preferred Stock exempt from reporting under Rule 16a-9(a).
- Reflects 183,907 shares of common stock received by the reporting person as a payment-in-kind dividend on Series A Preferred Stock and Series B Preferred Stock exempt from reporting under Rule 16a-9(a).
- Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.
- Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.
- Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019.
- Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering.